Insights

Partnership Opportunities Nimbus Therapeutics has a history of strategic partnerships with companies like Innovaderm Research Inc. and Anagenex, signaling potential collaboration avenues for sales partnerships and co-development opportunities.

Targeted Acquisition The acquisition of Nimbus Therapeutics by Takeda for $4B indicates an attractive target for companies looking to acquire innovative biotechnology firms, presenting a potential avenue for sales through acquisition discussions.

Expand Therapeutic Areas With the recent hiring of Anita Scheuber as Senior Vice President, Therapeutic Area Head, Oncology, Nimbus Therapeutics is poised to expand its presence in oncology, offering sales prospects in the growing oncology drug market.

Market Positioning Nimbus Therapeutics' focus on developing small molecule medicines using AI highlights a competitive edge in technology-driven drug discovery, presenting sales opportunities for companies seeking cutting-edge solutions in biotechnology research.

High Revenue Potential Nimbus Therapeutics' revenue in the range of $10M - $50M, coupled with a significant funding of $210M, indicates strong financial health and potential for high-value sales engagements in the biotechnology sector.

Nimbus Therapeutics Tech Stack

Nimbus Therapeutics uses 8 technology products and services including jQuery CDN, Drupal, Typekit, and more. Explore Nimbus Therapeutics's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Drupal
    Content Management System
  • Typekit
    Font Scripts
  • Microsoft
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Python
    Programming Languages
  • Conga Contracts
    Sales
  • AddThis
    Widgets

Media & News

Nimbus Therapeutics's Email Address Formats

Nimbus Therapeutics uses at least 1 format(s):
Nimbus Therapeutics Email FormatsExamplePercentage
first.last@nimbustx.comJohn.Doe@nimbustx.com
94%
last@nimbustx.comDoe@nimbustx.com
3%
flast@nimbustx.comJDoe@nimbustx.com
2%
fir.last@nimbustx.comJoh.Doe@nimbustx.com
1%

Frequently Asked Questions

Where is Nimbus Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Nimbus Therapeutics's main headquarters is located at 130 Prospect St Ste 301 Cambridge, Massachusetts 02139 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Nimbus Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Nimbus Therapeutics's main corporate office by phone at +1-857-999-2022. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nimbus Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Nimbus Therapeutics's official website is nimbustx.com and has social profiles on LinkedIn.

How much revenue does Nimbus Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, Nimbus Therapeutics's annual revenue reached $35M.

What is Nimbus Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Nimbus Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nimbus Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, Nimbus Therapeutics has approximately 106 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Business Officer: A. K.Chief People Officer: E. C.Chief Scientific Officer: P. T.. Explore Nimbus Therapeutics's employee directory with LeadIQ.

What industry does Nimbus Therapeutics belong to?

Minus sign iconPlus sign icon
Nimbus Therapeutics operates in the Biotechnology Research industry.

What technology does Nimbus Therapeutics use?

Minus sign iconPlus sign icon
Nimbus Therapeutics's tech stack includes jQuery CDNDrupalTypekitMicrosoftWP EnginePythonConga ContractsAddThis.

What is Nimbus Therapeutics's email format?

Minus sign iconPlus sign icon
Nimbus Therapeutics's email format typically follows the pattern of . Find more Nimbus Therapeutics email formats with LeadIQ.

How much funding has Nimbus Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, Nimbus Therapeutics has raised $210M in funding. The last funding round occurred on Sep 06, 2023.
Nimbus Therapeutics

Nimbus Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. With a decade-plus track record of success, we’ve built a world-class team in both computationally driven drug discovery and early clinical development while continuing to move the needle for patients. 

Section iconCompany Overview

Headquarters
130 Prospect St Ste 301 Cambridge, Massachusetts 02139 US
Phone number
+1-857-999-2022
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $210M

    Nimbus Therapeutics has raised a total of $210M of funding over 9 rounds. Their latest funding round was raised on Sep 06, 2023.

  • $10M$50M

    Nimbus Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $210M

    Nimbus Therapeutics has raised a total of $210M of funding over 9 rounds. Their latest funding round was raised on Sep 06, 2023.

  • $10M$50M

    Nimbus Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.